PRA: pediatric trials require specialized endpoints
A leader from the contract research organization explains how determining endpoints for such trials may require a different approach than for adults.
A leader from the contract research organization explains how determining endpoints for such trials may require a different approach than for adults.
UK-based Accord Healthcare has donated 2m tablets of the investigational drug hydroxychloroquine for the trial, which recently kicked off enrollment.
The company has been given the go-ahead to launch clinical research testing Nafamostat as a potential treatment for patients diagnosed with the virus.